CBX2 and breast cancer: Notably, the results demonstrated that CBX2 high mRNA expression was significantly correlated to shorter RFS in patients who have received adjuvant chemotherapy only (HR=2.78, p=3.5e-05) (Figure 4L), indicating a potential role of CBX2 in contribution to chemoresistance in BC.